DIY Loop user Taylor Patterson built an AI-powered food analysis tool right into the AID app—helping users take pictures, scan barcodes, or enter text and voice prompts to get carb estimates, nutrition breakdowns, and diabetes-oriented notes. In this episode, Taylor explains how he created the feature in just 30 minutes, how it’s already helping him improve his time in range, and why AI could change the way people with diabetes approach meals and treatment.

Join the Diabetech Newsletter

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up (US residents only)

Watch This Episode On Youtube

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

We cover ADCES 2025 updates on how diabetes educators are adapting to AI, new insights on mental health and eating disorders in type 1, and eye-opening stats about access to care. We also dive into the latest diabetes tech, including the Pivot pump, DIY systems, and carb awareness research. And lastly, we discuss major progress toward a cure for type 1 diabetes, with companies like Vertex and Sana moving faster than ever. I’m joined by two incredible diabetes educators, Mary Rose Deraco and Meg Moreta, to break it all down and share why education remains such a critical — and often overlooked — part of diabetes care.

Join the Diabetech Newsletter

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up (US residents only)

Watch This Episode On Youtube

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

We dive into the growing off-label use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro among people with type 1 diabetes. I'm joined by longtime diabetes advocate and healthcare executive Marie Schiller to explore the benefits, risks, and evolving research around these drugs. We discuss new studies, including the ADJUST-T1D trial, showing improved A1C, increased time in range, reduced insulin needs, and moderate weight loss—without major safety concerns. Marie shares her personal journey with GLP-1s, why they could be a game-changer when combined with AID systems, and the barriers to insurance coverage and FDA approval. The conversation also covers how people are accessing these medications, ongoing clinical trials, and the need for a multipronged treatment approach in type 1 care.

Join the Diabetech Newsletter

Learn about Omnipod 5 (today's sponsor)*

T1D Exchange Registry Sign up (US residents only)

Watch This Episode On Youtube

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.